Vaccine and Treatment Evaluation Units: Overall Administration, Clinical Operations Support and Concept and Protocol Development, Implementation and Assays for a Phase I Vaccine Trial for Schistosoma

疫苗和治疗评估单位：血吸虫 I 期疫苗试验的总体管理、临床操作支持以及概念和方案开发、实施和分析

• 批准号: 9915617
• 负责人: LISA JACKSON
• 金额: $ 8.58万
• 依托单位: KAISER FOUNDATION HEALTH PLAN OF WASHINGTON
• 依托单位国家: 美国
• 财政年份: 2018
• 资助国家: 美国
• 起止时间: 2018-07-12 至 2020-01-09
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9915617
• 关键词: Biological Assay; Clinical; Communicable Diseases; Conduct Clinical Trials; Contracts; Evaluation; Individual; Phase; Population; Resources; Schistosoma; Schistosoma mansoni; Vaccines; combat; design; named group; operation; programs; protocol development; vaccine trial

This program is comprised of a consortium of individual contracts within academic centers and organizations that provide a ready resource for the design and conduct of clinical trials to evaluate promising products to combat infectious diseases. In general, products will be evaluated in normal healthy populations; however, access to special populations is also available.

该计划由学术中心和组织内的个人合同联盟组成，为临床试验的设计和实施提供现成的资源，以评估有前景的抗击传染病的产品。一般来说，产品会在正常健康人群中进行评估；然而，也可以接触特殊人群。